Soluble oligomers for the diagnosis of neurodegenerative diseases

Author： El-Agnaf O.M.A. Walsh D.M. Allsop D.

Publisher： Elsevier

ISSN： 1474-4422

Source： Lancet Neurology, Vol.2, Iss.8, 2003-08, pp. : 461-462

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transglutaminase activation in neurodegenerative diseases

By Jeitner Thomas M Muma Nancy A Battaile Kevin P Cooper Arthur JL

Future Neurology, Vol. 4, Iss. 4, 2009-07 ,pp. : 449-467

Future Medicine

Access to resources Recommend Favorite

Polyphenols and neurodegenerative diseases

By Barreto George E. Guedes Rubem C. A.

Nutritional Neuroscience, Vol. 15, Iss. 3, 2012-05 ,pp. : 92-93

Maney Publishing

Access to resources Recommend Favorite

Molecular Mechanisms of Neurodegenerative Diseases, by

By Khachaturian Z.S.

Journal of Alzheimer's Disease, Vol. 3, Iss. 6, 2001-01 ,pp. : 601-602

Ios Press

Access to resources Recommend Favorite

Molecular Mechanisms of Neurodegenerative Diseases.

By Chinnery P.F.

Brain, Vol. 124, Iss. 7, 2001-07 ,pp. : 1467-1468

Oxford University Press

Access to resources Recommend Favorite

Nicotinic ion channel and neurodegenerative diseases

By Nakamura S. Sudoh S. Yamashita H. Yu-Xiang Z. Kawakami H. Takahashi T. Mimori Y.

Electroencephalography and Clinical Neurophysiology/ Electromyography and Motor Control, Vol. 97, Iss. 4, 1995-09 ,pp. : 42-43

Elsevier

Access to resources Recommend Favorite